Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer.


Journal

World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544

Informations de publication

Date de publication:
24 Apr 2023
Historique:
received: 26 05 2022
accepted: 18 03 2023
medline: 25 4 2023
pubmed: 24 4 2023
entrez: 23 04 2023
Statut: epublish

Résumé

Although synchronous multiple primary lung cancers (sMPLCs) are common in clinical practice, the choice of surgical modalities for the main lesion is still at the stage of exploration. This study is designed to analyze the prognosis of sMPLCs and single primary lung cancers with similar tumor stages and to explore whether sublobar resection has a similar prognosis as lobectomy for sMPLCs. One-hundred forty-one cases of sMPLCs were selected, including the following: 65 cases underwent lobectomy for main lesions, and 76 cases underwent sublobar resection for main lesions. One thousand one hundred forty-four cases of single primary lung cancer were matched at 1:1 by propensity score matching. Then, the patients with sMPLCs were divided into a lobectomy group and a sublobar group according to the first tumor stage. Ninety-eight cases of patients with sMPLCs were matched. The short-term perioperative effect, 5-year disease-free survival (DFS) rate, and 5-year overall survival (OS) rate between the two groups were compared. There was no significant difference in OS between sMPLCs and single primary lung cancer after lobectomy (77.1% vs. 77.2%, P = 0.157) and sublobar resection (98.7% vs. 90.7%, P = 0.309). There was no significant difference in OS (86.7% vs. 83.9%, P = 0.482) or DFS (67.6 vs. 87.7%, P = 0.324) between the lobectomy group and sublobar group with sMPLCs. The sublobar resection group obtained a lower incidence of postoperative complications (40.8% vs. 16.3%, P = 0.007) and shorter postoperative hospital stay (11.22 vs. 9.27, P = 0.049). The prognosis of patients with sMPLCs generally depends on the main tumor state, which has no statistical difference regardless of sublobar resection or lobectomy, and the perioperative period of sublobar resection is safer than that of lobectomy.

Identifiants

pubmed: 37088839
doi: 10.1186/s12957-023-02996-w
pii: 10.1186/s12957-023-02996-w
pmc: PMC10124016
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135

Subventions

Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : the program of Jiaxing Science and Technology Bureau
ID : 2017AY33007
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Zhejiang province medical and health technology
ID : 2021KY1016
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10
Organisme : Jiaxing Key Discipiline of Medicine - Thracic Surgery
ID : 2019-ZC-10

Informations de copyright

© 2023. The Author(s).

Références

Ann Thorac Surg. 2008 Jan;85(1):204-9
pubmed: 18154811
J Clin Oncol. 2014 Aug 10;32(23):2449-55
pubmed: 24982447
Lancet Respir Med. 2018 Dec;6(12):915-924
pubmed: 30442588
Ann Thorac Surg. 2001 Jan;71(1):309-13
pubmed: 11216767
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
J Thorac Cardiovasc Surg. 2007 May;133(5):1193-200
pubmed: 17467428
Ann Thorac Surg. 2015 Dec;100(6):2048-53
pubmed: 26277562
J Thorac Dis. 2017 Nov;9(11):4561-4573
pubmed: 29268526
Ann Thorac Cardiovasc Surg. 2013;19(5):341-4
pubmed: 23237928
Pathol Int. 2012 Dec;62(12):785-91
pubmed: 23252867
Eur J Cardiothorac Surg. 2001 Sep;20(3):489-95
pubmed: 11509268
J Thorac Dis. 2018 Feb;10(2):790-798
pubmed: 29607150
Lung Cancer. 2014 Jul;85(1):7-11
pubmed: 24768582
Zhongguo Fei Ai Za Zhi. 2017 Jan 20;20(1):21-27
pubmed: 28103969
Aging (Albany NY). 2021 Mar 10;13(6):8737-8761
pubmed: 33714956
Ann Thorac Surg. 2013 Dec;96(6):1966-74
pubmed: 24021769
Chest. 2013 May;143(5 Suppl):e369S-e399S
pubmed: 23649447
Cancer. 2016 May 1;122(9):1312-37
pubmed: 26959385
Eur J Cardiothorac Surg. 2000 Nov;18(5):529-34
pubmed: 11053812
Funct Integr Genomics. 2022 Oct;22(5):1057-1072
pubmed: 35851932
Chest. 1997 Sep;112(3):693-701
pubmed: 9315801
J Thorac Cardiovasc Surg. 2007 Sep;134(3):630-7
pubmed: 17723810
Eur J Cardiothorac Surg. 2002 Mar;21(3):527-33
pubmed: 11888775
Mod Pathol. 2011 May;24(5):653-64
pubmed: 21252858
N Engl J Med. 2006 Oct 26;355(17):1763-71
pubmed: 17065637
Ann Thorac Surg. 2004 Oct;78(4):1194-9
pubmed: 15464469
J Thorac Cardiovasc Surg. 1975 Oct;70(4):606-12
pubmed: 170482
Eur J Cardiothorac Surg. 2018 Feb 1;53(2):366-371
pubmed: 28958068
Ann Thorac Surg. 1991 Oct;52(4):773-8; discussion 778-9
pubmed: 1929628
Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3
pubmed: 7677489
Medicine (Baltimore). 2016 Nov;95(46):e5457
pubmed: 27861398
Eur Respir J. 2012 Jun;39(6):1437-42
pubmed: 22075483
Chest. 2000 Dec;118(6):1621-5
pubmed: 11115449
Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):826-831
pubmed: 27401084
Cancers (Basel). 2021 Jul 19;13(14):
pubmed: 34298828
Oncol Lett. 2012 Jan;3(1):234-237
pubmed: 22740887
Ann Thorac Surg. 2014 Dec;98(6):1983-8
pubmed: 25443005

Auteurs

Niu Niu (N)

Department of Cardiothoracic Surgery, First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), Jiaxing, 314000, China.

Liang Zhou (L)

Graduate School of Bengbu Medical College, Bengbu, 233000, China.

Junjie Zhao (J)

Department of Cardiothoracic Surgery, First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), Jiaxing, 314000, China.

Xingjie Ma (X)

Department of Cardiothoracic Surgery, First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), Jiaxing, 314000, China.

Fan Yang (F)

Department of Cardiothoracic Surgery, First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), Jiaxing, 314000, China.

Weibo Qi (W)

Department of Cardiothoracic Surgery, First Hospital of Jiaxing (Affiliated Hospital of Jiaxing University), Jiaxing, 314000, China. qiweibo1121@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH